W 771 (Ropinirole Hydrochloride Extended-Release 2 mg)
Pill with imprint W 771 is Pink, Round and has been identified as Ropinirole Hydrochloride Extended-Release 2 mg. It is supplied by Wockhardt Limited.
Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for W 771
Ropinirole Hydrochloride Extended-Release
- Imprint
- W 771
- Strength
- 2 mg
- Color
- Pink
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Wockhardt Limited
- National Drug Code (NDC)
- 64679-0771
- Inactive Ingredients
-
carboxymethylcellulose sodium,
ethylcelluloses,
ferric oxide red,
ferric oxide yellow,
hydrogenated castor oil,
hypromelloses,
magnesium stearate,
maltodextrin,
polyethylene glycol 400,
povidone k30,
silicon dioxide,
corn starch,
titanium dioxide,
triethyl citrate
Note: Inactive ingredients may vary.
Related Images for "W 771"
More about ropinirole
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 289 Reviews
- Drug class: dopaminergic antiparkinsonism agents
- FDA Alerts (1)
Consumer resources
- Patient Information
- Ropinirole (Advanced Reading)
- Ropinirole Extended-Release Tablets
- Ropinirole Tablets
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.